Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:16 PM
Ignite Modification Date:
2025-12-24 @ 4:16 PM
NCT ID:
NCT05718466
Eligibility Criteria:
Inclusion Criteria:
* Histologically proven intracranial glioblastoma multiforme with pathologic or imaging confirmation of tumor progression or regrowth after failure of two previous treatment regimens
* Initial low-grade glioma and a subsequent diagnosis of glioblastoma or gliosarcoma
* History and physical exam, including neurologic examination, within 4 weeks prior to registration
Exclusion Criteria:
• Warfarin or LMW heparin patients must have no active bleeding or pathological condition that carries a high risk of bleeding
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
100 Years
Study:
NCT05718466
Study Brief:
Protocol Section:
NCT05718466